Cytokinetics (CYTK) Misses Q3 EPS by 35c
Tweet
Share
E-mail
Get Alerts CYTK Hot Sheet
Price: $82.19 +1.72%
EPS Growth %: -46.4%
Financial Fact:
General and administrative: 7.22M
Today's EPS Names:
CGEH, NAKA, APOG, More
EPS Growth %: -46.4%
Financial Fact:
General and administrative: 7.22M
Today's EPS Names:
CGEH, NAKA, APOG, More
Join SI Premium – FREE
Cytokinetics (NASDAQ: CYTK) reported Q3 EPS of ($1.52), $0.35 worse than the analyst estimate of ($1.17). Revenue for the quarter came in at $2.52 million versus the consensus estimate of $3.16 million.
For earnings history and earnings-related data on Cytokinetics (CYTK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
- Hyperscale Data acquires 48.5 acres to expand Michigan campus
- Apple’s big price hike seen as "an unprecedented push to protect margins"
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
